Selective resonance of chemical structures

• US 8,364,423 B2
• Filed: 06/03/2011
• Issued: 01/29/2013
• Est. Priority Date: 07/21/2005
• Status: Expired due to Fees

• Current Assignee: Enterprise Science Fund, LLC (Intellectual Ventures LLC)
• Original Assignee: The Invention Science Fund I, L.L.C. (Intellectual Ventures LLC)
• Inventors: Ishikawa, Muriel Y., Jung, Edward K. Y., Myhrvold, Nathan P., Wood, Lowell L. Jr.
• Primary Examiner(s): Lin, Jerry
• Application Number:
  US13/134,267
• Publication Number:
  US 20110245739A1
• Time in Patent Office: 606 Days
• Field of Search: 702/30
• US Class Current: 702/30
• CPC Class Codes: A61B 2018/00577 Ablation
• CPC Class Codes: A61B 5/0059 using light, e.g. diagnosis by transillumination, diascopy, fluorescence A61B5/0093, A61B5/1455, A61B5/02416 and A61B5/0261 take precedence
• CPC Class Codes: A61K 41/0004 Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
• CPC Class Codes: A61N 5/00 Radiation therapy ultrasound therapy A61N7/00; devices or apparatus applicable to both therapy and diagnosis A61B6/00
• CPC Class Codes: A61N 5/062 Photodynamic therapy, i.e. excitation of an agent

Abstract

Chemical compositions in the blood may be selectively or preferentially excited by the application of scores comprising a series of at least four energy inputs to a blood vessel.

Claims

1. A blood therapy device, comprising:

an energy input component, adapted to be placed on or in a human or animal body, that directs a set of at least four differing energy inputs towards a blood vessel, wherein the set of differing energy inputs selectively resonates a plurality of resonant structures in a target composition in the blood.

2. The blood therapy device of claim 1, further comprising a monitor that observes effects of the resonance of the plurality of resonant structures.

3. The blood therapy device of claim 2, wherein the monitor measures a property of the target composition selected from the group consisting of energy levels, kinetic effects, structural changes, chemical activities, index of refraction, diffraction properties, optical absorption, temperature, and combinations thereof.

4. The blood therapy device of claim 1, wherein the resonance of the plurality of resonant structures destroys the target composition, and wherein the target composition is a virus.

5. The blood therapy device of claim 1, wherein the resonance of the plurality of resonant structures destroys the target composition, and wherein the target composition is a biomolecule.

6. The blood therapy device of claim 5, wherein the biomolecule is selected from the group consisting of proteins, sugars, triglycerides, and cholesterols.

7. The blood therapy device of claim 1, wherein the resonance of the plurality of resonant structures destroys the target composition, and wherein the target composition is a pharmaceutical.

8. The blood therapy device of claim 7, wherein the pharmaceutical is heparin.

9. The blood therapy device of claim 1, wherein the resonance of the plurality of resonant structures modifies the target composition.

10. The blood therapy device of claim 9, wherein the target composition is a protein.

11. The blood therapy device of claim 1, wherein the energy input component directs the set of at least four differing energy inputs into the body through the skin.

12. The blood therapy device of claim 1, wherein the plurality of resonant structures in the target composition are resonated sequentially.

13. The blood therapy device of claim 1, wherein the plurality of resonant structures in the target composition are resonated simultaneously.

14. The blood therapy device of claim 1, wherein the plurality of resonant structures in the target composition are resonated in a temporally overlapping fashion.

16. The blood therapy device of claim 1, wherein the target composition is a molecule.

17. The blood therapy device of claim 1, wherein the set of at least four differing energy inputs selectively resonates the plurality of resonant structures in a vibrational mode.

15. A method, comprising:

placing an energy input component on or in a human or animal body; and

directing a set of at least four differing energy inputs from the energy input component towards a blood vessel of the human or animal body, wherein the set of at least four differing energy inputs selectively resonates a plurality of resonant structures in a target composition in the blood.